In previous studies, an increased level of CDH3 has been detected in a small cohort of BRCA1-deficient breast cancer [15], as well as in nipple aspirate fluid and serum obtained from women with basal-like breast tumors [14]. This evidence concerns the gene BRCA1 and breast carcinoma.